![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 6, 4864-4872, February 11, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶**

From the
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, the
Department of Molecular Genetics and Microbiology, the ||Department of Cell Biology, the **Department of Immunology, and the ¶Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710
Pseudomonas aeruginosa is a major cause of pneumonia in patients with cystic fibrosis and other immuncompromising conditions. Here we showed that P. aeruginosa invades type I pneumocytes via a lipid raft-mediated mechanism. P. aeruginosa invasion of rat primary type I-like pneumocytes as well as a murine lung epithelial cell line 12 (MLE-12) is inhibited by drugs that remove membrane cholesterol and disrupt lipid rafts. Confocal microscopy demonstrated co-localization of intracellular P. aeruginosa with lipid raft components including caveolin-1 and -2. We generated caveolin-1 and -2 knockdowns in MLE-12 cells by using RNA interference techniques. Decreased expression of caveolin-2 significantly impaired the ability of P. aeruginosa to invade MLE-12 cells. In addition, the lipid raft-dependent tyrosine phosphorylation of caveolin-2 appeared to be a critical regulator of P. aeruginosa invasion.
Received for publication, October 14, 2004 , and in revised form, November 12, 2004.
* This work was supported by National Institute of Health Grants 1F32-DK065412, 5R01 AI150021-03, 1 R21 AI056101-01A1, and 5 R01 HL68072 and by a Senior Investigator award from the Sandler Family Foundation on Asthma Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Duke University Medical Center, Box 3020, Duke University Medical Center, Durham, NC 27710. Tel.: 919684-6942; Fax: 919-684-2021; E-mail: soman.abraham{at}duke.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Kannan, A. Audet, H. Huang, L.-j. Chen, and M. Wu Cholesterol-Rich Membrane Rafts and Lyn Are Involved in Phagocytosis during Pseudomonas aeruginosa Infection J. Immunol., February 15, 2008; 180(4): 2396 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Reiniger, M. M. Lee, F. T. Coleman, C. Ray, D. E. Golan, and G. B. Pier Resistance to Pseudomonas aeruginosa Chronic Lung Infection Requires Cystic Fibrosis Transmembrane Conductance Regulator-Modulated Interleukin-1 (IL-1) Release and Signaling through the IL-1 Receptor Infect. Immun., April 1, 2007; 75(4): 1598 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Garcia-Medina, W. M. Dunne, P. K. Singh, and S. L. Brody Pseudomonas aeruginosa Acquires Biofilm-Like Properties within Airway Epithelial Cells Infect. Immun., December 1, 2005; 73(12): 8298 - 8305. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kierbel, A. Gassama-Diagne, K. Mostov, and J. N. Engel The Phosphoinositol-3-Kinase-Protein Kinase B/Akt Pathway Is Critical for Pseudomonas aeruginosa Strain PAK Internalization Mol. Biol. Cell, May 1, 2005; 16(5): 2577 - 2585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |